Amos Bairoch | |
---|---|
Amos Bairoch
|
|
Born | November 22, 1957 |
Fields | Bioinformatics |
Institutions | Swiss Institute of Bioinformatics |
Alma mater | University of Geneva[1] |
Doctoral students | Alexandre Gattiker Pavel Dobrokhotov Fabrice David[1] |
Known for | Swiss-Prot[2], ExPASy[3] |
Notable awards | European Latsis Prize (2004), Otto Naegeli prize (2010) |
Amos Bairoch is a Swiss bioinformatician, born 22 November 1957[4].
Bairoch is currently professor of Bioinformatics at the Department of Structural biology and Bioinformatics of the University of Geneva and group leader at the Swiss Institute of Bioinformatics (SIB). He has created at the SIB a new group called CALIPHO (Computer Analysis and Laboratory Investigation of Proteins of Human Origin)[5] to combine bioinformatics, curation, and experimental efforts to functionally characterize human proteins [6].
His main work[7][8] is in the field of protein sequence analysis and more particularly in the development of databases and software tools for this purpose. His most important contribution is the input of human knowledge by careful manual annotation in protein-related data.[9] His first project, as a Ph.D. student was the development of PC/Gene[10], an MS-DOS based software package for the analysis of protein and nucleotide sequences. PC/Gene was commercialized, first by a Swiss company (Genofit) then by Intelligenetics in the US which was later bought by Oxford Molecular.
While working on PC/Gene he started to develop an annotated protein sequence database which became Swiss-Prot and was first released in July 1986.[11] From 1988 onward it has been a collaborative project with the Data Library group of the European Molecular Biology Laboratory which later evolved into the European Bioinformatics Institute (EBI).
The Swiss-Prot database is the primary protein sequence resource in the world and has been a key research instrument for both bioinformaticians and laboratory-based scientists in a very wide range of applications.[12] A measure of its success is the recent development of UniProt, the world’s most comprehensive catalogue of information on proteins.[13] UniProt is a central information resource of protein sequences and functions created by joining the information contained in Swiss-Prot, TrEMBL, and the American Protein Information Resource databases.
In 1988 he started to develop PROSITE[14], a database of protein families and domains. A little while later he created ENZYME, a nomenclature database on enzymes as well as SeqAnalRef[15], a sequence analysis bibliographic reference database,.[16][17]
In collaboration with Ron Appel he initiated, in August 1993, the first molecular biology WWW server, ExPASy[18]. What was intended as a prototype grew rapidly into a major site that provides access to the many databases produced partially or completely in Geneva as well as many tools for the analysis of proteins (proteomics).
In 1998, with colleagues in Geneva and Lausanne, he was one of the founders of the Swiss Institute of Bioinformatics (SIB), whose mission is to establish in Switzerland a center of excellence in the field of bioinformatics with an emphasis on research, education, services and the developments of databases and tools.[19]
In November 1997, together with Ron Appel and Denis Hochstrasser, he founded GeneBio (Geneva Bioinformatics SA), a company involved in biological knowledge. In April 2000, the above persons with Keith Rose and Robin Offord founded GeneProt (Geneva Proteomics), a high throughput proteomics company that ceased operations in 2005.
Since 2009, in the framework of the CALIPHO group, directed by himself and Lydie Lane, he is involved in the development of neXtProt a new resource which aim to provide life scientists with a broad spectrum of knowledge on all human proteins.
He is recipient of the 1993 Friedrich Miescher Award from the Swiss Society of Biochemistry, the 1995 Helmut Horten Foundation Incentive Award, the 2004 Pehr Edman award, the 2004 European Latsis Prize, the 2010 Otto Naegeli prize, and the 2011 HUPO Distinguished Achievement Award in Proteomic Sciences[1].
“ | As the process keeps going down we're reaching the point where every genome that can be sequenced will be sequenced.[20] | ” |